Budapest, Hungary

Laszlone Mohai

This inventor holds 1 USPTO granted patent. Top assignee: Gyogyszerkutato Intezet Kft.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laszlone Mohai. Retrieved from https://idiyas.com/inventor/laszlone-mohai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Laszlone Mohai in Anticoagulant Research

Introduction

Laszlone Mohai, an accomplished inventor based in Budapest, Hungary, has made significant strides in the field of pharmaceuticals. With a focus on anticoagulant peptide derivatives, her work holds promise for advancements in medical treatments.

Latest Patents

Mohai is credited with one patent: "Anticoagulant peptide derivatives and pharmaceutical compositions." This innovation represents a meaningful contribution to the development of effective therapies for conditions that require the management of blood coagulation.

Career Highlights

She works at Gyogyszerkutato Intezet Kft., a research institution dedicated to the development of innovative pharmaceutical products. Mohai’s expertise and dedication to her field have led to her involvement in groundbreaking research that enhances our understanding of anticoagulants.

Collaborations

In her career, Laszlone Mohai has collaborated with notable coworkers such as Sandor Bajusz and Daniel Bagdy. Their combined efforts in research underscore the importance of teamwork in the pursuit of scientific advancements.

Conclusion

Laszlone Mohai’s contributions to anticoagulant research not only showcase her ingenuity as an inventor but also highlight the ongoing need for innovative solutions in healthcare. Her dedication to research at Gyogyszerkutato Intezet Kft. exemplifies the impact of collaboration and creativity in the field of pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…